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Current contrast agents for MRI are Gd3+-based, which successfully enhance image contrast.  
These agents, however, are limited in detecting certain analytes associated with disease 
compared to new agents that operate through a CEST mechanism. In this study, both Eu3+ and 
Tm3+ chelates were examined as CEST agents for MRI imaging as a function of Zn2+ 
concentration. T1 values were obtained using NMR spectrometry; these values were then used to 
fit the CEST data obtained for the compounds. The CEST spectra of the Tm3+ chelate were 
useful for examining CEST arising from the amide protons. A shift in the amide protons was 
observed as Zn2+ concentrations increased indicating a presence of multiple species and a change 
in coordination chemistry. The change of the amide peak at -52 ppm showed its potential to be 
used as a marker for Zn2+ concentration. The Eu3+ chelate was useful for examining CEST 
arising from the coordinated water. A distinct change in the water peak shape, intensity, and shift 




Over time, magnetic resonance imaging has become an indispensable tool both in diagnostic 
medicine as well as biomedical research. The mechanism by which MRI obtains images is 
through the principle of Nuclear Magnetic Resonance (NMR). If a sample is placed in a magnet 
the spins of the nuclei either orient along or against the magnetic field with the majority of the 
spins aligned along the magnetic field.18 The bulk magnetization is therefore aligned along the z 
axis as seen in Figure 1.18 The net magnetization has a torque and precesses at a specific 
frequency called the Larmor frequency.12 This precessing magnetic field causes a current in a 
nearby magnetic coil, which generates a signal. A radiofrequency pulse is then applied which 
results in more spins being oriented against the magnetic field and reduces the bulk 
magnetization.18 The intensity of the signals produced in experiments with NMR and MRI are 
proportional to the net magnetization. Radiofrequency energy can be applied to the net 
magnetization causing two effects depending on the duration of the pulse. If a short duration, 
high power, pulse is applied excitation of the nuclei is observed. If a long duration, low power, 
pulse is applied saturation will occur.  When energy is no longer added, the spins will relax back 
to their original, low energy-α, states.  
  
Figure 1. The vector on the z axis represents the bulk magnetization of a sample (left). A 
radiofrequency pulse results in more high energy-β spins and a lower magnitude of the bulk 
magnetization (right).18 
Often times in MRI differentiating between different tissue types is difficult and an exogenous 
agent must be used. These exogenous agents, or contrast agents, will enhance the signal in 
specific regions as the agent gets distributed throughout the body by altering T1, T2 or both.16  
Most commonly used contrast agents are gadolinium(III) complexes, small paramagnetic metal 
complexes, which shorten the relaxation times of the water protons by increasing the rate of 
longitudinal water proton relaxation and thereby result in an increase of signal intensity.18,19 The 
relaxivity of an agent is known as the water proton relaxation rate per unit concentration of 
contrast agent and an increase in relaxivity results in a more effective reduction in T1.19 
However, Gd3+-based agents have their drawbacks as well. Current Gd3+ contrast agents flow 
throughout all extracellular space, have comparatively low relaxivities of 4-5 mM-1s-1 [2] and 
must be provided in comparatively high doses of about 0.1 mmol kg-1.19  
A new group of contrast agents have been found by Balaban et al16, which may be used for MRI.  
These agents possess slowly exchanging –NH or –OH protons and operate through a Chemical 
Exchange Saturation Transfer, or CEST, of pre-saturated spins to bulk water.16,17 In a CEST 
mechanism a nucleus is exchanged from one site to a chemically different site.18 This process is  
  
Figure 2. When a presaturation pulse is applied to Pool B the number of high energy spins 
increases. Given that the chemical exchange rate is large enough to overcome the effects of 
relaxation, chemical exchange will occur. If not, the high energy spins will relax back to 
equilibrium.18 
in competition with relaxation and can be seen in Figure 2.18  The CEST process would occur in a 
system that has two pools, A and B, of exchanging protons as long as the pools have relaxation 
times that are longer than the exchange rates.18 The exchange rates should also be as fast as 
possible to reduce relaxation effects.18 Following a presaturation pulse, Pool A would have an 
increase in high energy spins, against the magnetic field, and a decrease in low energy spins, 
along the magnetic field.18 This moves Pool A closer to saturation, reducing the bulk 
magnetization and the signal intensity. Pool B would have a signal intensity of almost 0.18 Using 
this mechanism, signal intensity of one resonance can therefore be altered by applying a 
presaturation pulse to a second resonance that is in exchange with the first resonance and 
ultimately use this effect to change signal intensity to produce contrast in MRI images.18  
Paramagnetic compounds that have exchangeable proton sites (-NH, -OH or H2O) frequency 
shifted away from the bulk water NMR frequency may increase the effectiveness of a CEST 
agent by maximizing the frequency difference between the two pools, Δω, and consequently also 
the rate of chemical exchange.18 These compounds are called PARACEST agents. Another 
advantage of PARACEST agents is their ability to act as “smart” agents and respond to changes 
in molecular concentrations within the body.18 So far, systems that are capable of reporting a 
number of biologically relevant variables have been constructed, such as: pH, temperature, 
lactate, glucose and zinc.1 
Divalent zinc is the second most abundant transition-metal ion in the human body4,9,11,14 and 
deficiency in the ion affects digestive, immune and neuronal systems.10,14,15 It has also been 
found to be important for regulation of cell death and synaptic transmission,3 but perhaps most 
importantly Zn2+ is bound up with insulin in pancreatic β-cells. Because Zn2+ is co-released with 
insulin in response to elevated glucose levels imaging the presence of Zn2+ could be beneficial to 
the medical field and to understanding diabetes in particular. In the human body, Zn2+ exists both 
as bound Zn2+ and free Zn2+. Bound Zn2+ can be found on membrane receptors, transporters and 
channels regulating their activity.7 Bound Zn2+ on loosely bound metal-protein complexes in 
certain cell types and organelles are released to form free Zn2+ ion concentrations ranging from 
10-12-10-5 Μ to about 0.3 mM.1,5,8 To be able to study how and why it is released inside the body 
a mode of detection will be necessary. In the past there has been success in sensing Zn2+ ions 
using Gd3+ complexes, where the first one designed decreased water relaxivity by about 30% 
when Zn2+ was present.6 A CEST agent with Eu3+ has also been designed and was shown to be 




Figure 3. The two contrast agents studied were the thulium complex (left) and europium 
complex (right). 
 
Two contrast agents were studied, including a thulium complex and a europium complex. The 
structures of these contrast agents can be seen in Figure 3. Each complex was studied in four 
separate samples of varying Zn2+ concentration: 0, 0.5, 1, and 2 Eq Zn2+. They were then 
analyzed on a Bruker 600 MHz NMR spectrometer to obtain T1 values of bulk water. All T1 
values were measured through saturation recovery except for the europium with zero equivalents 
of Zn2+, which was measured through inversion recovery. The T1 values were then used to fit the 
data on MATLAB software.  
Results  
The T1 values for the Tm3+ samples with 0, 0.5, 1 and 2 equivalents of Zn2+ were 0.377 s, 0.370 
s, 0.365 s, and 0.396 s respectively. The T1 values for the Eu3+ samples with the same Zn2+ 
equivalents were 3.384 s, 2.489 s, 2.559 s, and 2.587 s respectively.  
Eqs of Zn2+  0 0.5 1 2 
[EuL] (mM) 12.778 8.333 6.945 5.833 
τM (us) 293.3 105.1 76 67.2 
τNH (ms) 5 0.9588 0.84 0.5009 
δ H2O 0.3357 0.5913 0.4711 0.4644 
δ bound 50.8941 50.8218 50.6135 49.3208 
δ NH -4.5 -5.0554 -4.8617 -5.1599 
T1 bulk 2.48 2.25 2.55 2.58 
T2 bulk 0.6748 0.8082 0.8576 0.5707 
T1 bound 0.045 0.03 0.03 0.03 
T2 bound 0.01 0.01 0.01 0.01 
T1 NH 1.5 1.5 1.5 1.5 
T2 NH 1.5 0.3 0.3001 1.5 
Table 1. Fitting parameters for the Eu3+ chelate. 
 
[Zn] = 0 0.5 1 2 
τM (µs) 2711.3 4094 972.1 1465.5 
τNH (ms) 2.169 1.2081 2.9585 0.7353 
δ H2O -0.1747 -0.2936 -0.4485 -0.7757 
δ bound -48.2598 -47.5 -51.5 -50.7996 
δ NH -51.8 -52 -59.5 -59.6928 
T1 bulk 0.3806 0.3719 0.3669 0.3999 
T2 bulk 0.0045 0.0045 0.0053 0.0091 
T1 bound 0.0005 0.0006 0.1396 0.0018 
T2 bound 0.001 0.001 0.0004 0.0003 
T1 NH 0.0005 0.0012 0.2 0.0019 
T1 NH 0.0006 0.0003 0.0045 0.0003 
Table 2. Fitting parameters for the Tm3+ chelate. 
 
The T1 of bulk water was constrained to these T1 values and CEST spectra were fitted to the 
Bloch equations using a three-pool model of bulk, bound and NH. The other T1 and T2 values 
were constrained to reasonable values. The fitting parameters are shown in Table 1 and 2 for the 
Eu3+ and Tm3+ chelates respectively. 
 
Figure 4. Full CEST spectra of the Tm3+ chelate with 0, 0.5, 1 and 2 equivalents of Zn2+ (left) 
and just the two amide peaks (right). 
 
The full CEST spectra of the Tm3+ chelate (Figure 4) was visualized for the four samples. The 
two peaks corresponding to the amide protons, which were expected for a chelate with C2 
symmetry, can be seen closer on the right of Figure 4. Prior to any addition of Zn2+ the two 
CEST peaks were at -48 ppm and -52 ppm, with the downfield, -48 ppm, peak having greater 
intensity. At half of an equivalent of Zn2+ the peaks were at the same location, however the 
upfield peak, -52 ppm, became ore intense. After the addition of one equivalent of Zn2+ the two 
amide peaks shifted to -52 ppm and -60 ppm with the downfield peak, -52 ppm, being more 
 
Figure 5. CEST for the two amide protons at -52 ppm and -60 ppm on the Tm3+ chelate with 
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intense. At two equivalents of Zn2+ the peaks experienced no shift, however the upfield peak, -60 
ppm, was the most intense. Overall, with increasing concentrations of Zn2+, CEST at -60 ppm  
decreased from 0.934 to 0.844 and CEST at -52 ppm increased from 0.868 to 0.884 (Figure 5). 
The ratio of -52 to -60 increased from 0.93 to 1.05 as the concentration of Zn2+ increased.  
 
Figure 6. Full CEST spectra of the Eu3+ chelate with 0, 0.5, 1 and 2 equivalents of Zn2+ (left) 
and just the bound water peak (right). 
 
CEST spectra of the Eu3+chelate (Figure 6) showed the bound water peak at 50 ppm and the bulk 
water peak centered at 0 ppm. A closer view of the bound water peak shows that as the 
concentration of Zn2+ increases, the peak broadens, reduces in intensity and shifts toward the   
bulk water peak upfield. Titration of the Eu3+ chelate with 0 to 2.25 equivalents of Zn2+ resulted 
 
Figure 7. 1H NMR Spectrum from titrating the Eu3+ chelate with varying concentrations, 0 to 
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in a noticeable change in the 1H NMR spectrum with increasing Zn2+ concentration, especially 
exceeding one equivalent (Figure 7).   
Discussion 
The shift of the amide protons in the CEST spectra of the Tm3+ chelate makes it likely that there 
is a different chelate structure in the presence of Zn2+ than when Zn2+ is absent. This was 
supported by the change in the 1H NMR spectrum following titration of Zn2+ into a solution of 
the Eu3+ chelate. When examining the CEST spectra of the two amide protons it can be seen that 
the upfield CEST peak without Zn2+ and the downfield CEST peak with Zn2+ both occur at -52 
ppm, but vary in their intensity. This change in intensity in the presence of Zn2+ could make it 
usable as a marker for Zn2+ concentration. The peak at -60 ppm can be used as a reporter of the 
Zn2+ concentration in a ratiometric method, but the peak at -48 ppm may be too weak. Figure 4 
further indicates the presence of multiple species as Zn2+ is added to solution. The line 
broadening is the result of individual species having different shifts as well as the changing 
exchange rate. This causes the appearance of deceivingly faster exchange rates. It may also 
explain why the concentration of chelate appears to decrease with increasing Zn2+ 
concentrations.  
The broadening, shifting, and reduction in intensity of the bound water peak of the Eu3+ CEST 
spectra indicates that water exchange kinetics are increasing with the presence of Zn2+. The fit 
was also not adequate on the bound water peaks when concentration of the CEST agent was kept 
constant and consistent with the known initial concentration. Only when the concentration was 
progressively decreased for each sample did the data fit better.  The concentration values in 
Table 1 also show that with added Zn2+ a reduction in the hydration state or exchange capacity of 
the CEST agent is observed. 
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